Ernexa Therapeutics to Present at Oxford Global’s Cell 2025
Provided By GlobeNewswire
Last update: Nov 11, 2025
CAMBRIDGE, Mass., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Ernexa Therapeutics (Nasdaq: ERNA), an industry innovator developing novel cell therapies for the treatment of advanced cancer and autoimmune disease, today announced it will present at Cell 2025, Oxford Global’s premier event, being held on November 11 and 12, 2025 in London, UK.
Read more at globenewswire.com
